The inactivation of tolC sensitizes Escherichia coli to perturbations in lipopolysaccharide transport
Shawna Zhu,
Mary Kate Alexander,
Telmo O. Paiva,
Kenneth Rachwalski,
Anh Miu,
Yiming Xu,
Vishal Verma,
Mike Reichelt,
Yves F. Dufrêne,
Eric D. Brown,
Georgina Cox
Affiliations
Shawna Zhu
College of Biological Sciences, Department of Molecular and Cellular Biology, University of Guelph, 50 Stone Road E, Guelph, ON N1G 2W1, Canada
Mary Kate Alexander
Genentech Inc, Infectious Diseases, South San Francisco, CA, USA
Telmo O. Paiva
Institute of Life Sciences, UCLouvain, Croix du Sud, 4-5, bte L7.07.06, B-1348 Louvain-la-Neuve, Belgium
Kenneth Rachwalski
Biochemistry and Biomedical Sciences and Degroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4L8, Canada
Anh Miu
Genentech Inc, Biochemical and Cellular Pharmacology, South San Francisco, CA, USA
Yiming Xu
Genentech Inc, Infectious Diseases, South San Francisco, CA, USA
Vishal Verma
Genentech Inc, Discovery Chemistry, South San Francisco, CA, USA
Mike Reichelt
Genentech Inc, Pathology, South San Francisco, CA, USA
Yves F. Dufrêne
Institute of Life Sciences, UCLouvain, Croix du Sud, 4-5, bte L7.07.06, B-1348 Louvain-la-Neuve, Belgium
Eric D. Brown
Biochemistry and Biomedical Sciences and Degroote Institute for Infectious Disease Research, McMaster University, Hamilton, ON L8S 4L8, Canada
Georgina Cox
College of Biological Sciences, Department of Molecular and Cellular Biology, University of Guelph, 50 Stone Road E, Guelph, ON N1G 2W1, Canada; Corresponding author
Summary: The Escherichia coli outer membrane channel TolC complexes with several inner membrane efflux pumps to export compounds across the cell envelope. All components of these complexes are essential for robust efflux activity, yet E. coli is more sensitive to antimicrobial compounds when tolC is inactivated compared to the inactivation of genes encoding the inner membrane drug efflux pumps. While investigating these susceptibility differences, we identified a distinct class of inhibitors targeting the core-lipopolysaccharide translocase, MsbA. We show that tolC null mutants are sensitized to structurally unrelated MsbA inhibitors and msbA knockdown, highlighting a synthetic-sick interaction. Phenotypic profiling revealed that tolC inactivation induced cell envelope softening and increased outer membrane permeability. Overall, this work identified a chemical probe of MsbA, revealed that tolC is associated with cell envelope mechanics and integrity, and highlighted that these findings should be considered when using tolC null mutants to study efflux deficiency.